Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
358.13
-4.21 (-1.16%)
At close: Oct 9, 2025, 4:00 PM EDT
358.50
+0.37 (0.10%)
After-hours: Oct 9, 2025, 4:05 PM EDT
Elevance Health Analyst Ratings
Total Analysts
14
Consensus Rating
Buy
Price Target
$403.38
Upside
+12.64%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $342 → $420 | Buy | Maintains | $342 → $420 | +17.28% | Oct 9, 2025 |
| Barclays | Barclays | Buy Maintains $373 → $395 | Buy | Maintains | $373 → $395 | +10.30% | Oct 9, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $360 → $398 | Strong Buy | Maintains | $360 → $398 | +11.13% | Oct 8, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $330 → $412 | Buy | Maintains | $330 → $412 | +15.04% | Oct 7, 2025 |
| UBS | UBS | Strong Buy Maintains $435 → $425 | Strong Buy | Maintains | $435 → $425 | +18.67% | Sep 5, 2025 |
| Barclays | Barclays | Buy Maintains $327 → $373 | Buy | Maintains | $327 → $373 | +4.15% | Sep 4, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $400 → $330 | Buy | Maintains | $400 → $330 | -7.85% | Aug 15, 2025 |
| Baird | Baird | Hold Maintains $492 → $297 | Hold | Maintains | $492 → $297 | -17.07% | Jul 25, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $472 → $384 | Buy | Maintains | $472 → $384 | +7.22% | Jul 22, 2025 |
| Barclays | Barclays | Buy Maintains $358 → $327 | Buy | Maintains | $358 → $327 | -8.69% | Jul 22, 2025 |
| Argus Research | Argus Research | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 21, 2025 |
| UBS | UBS | Strong Buy Maintains $484 → $435 | Strong Buy | Maintains | $484 → $435 | +21.46% | Jul 18, 2025 |
| Barclays | Barclays | Buy Maintains $434 → $358 | Buy | Maintains | $434 → $358 | -0.04% | Jul 18, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $447 → $360 | Strong Buy | Maintains | $447 → $360 | +0.52% | Jul 18, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $428 → $316 | Buy | Maintains | $428 → $316 | -11.76% | Jul 18, 2025 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $510 → $310 | Buy → Hold | Downgrades | $510 → $310 | -13.44% | Jul 18, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.